These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19936237)

  • 41. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer's Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation.
    Zhou C; Jung CG; Kim MJ; Watanabe A; Abdelhamid M; Taslima F; Michikawa M
    Mol Neurobiol; 2022 Sep; 59(9):5408-5425. PubMed ID: 35701718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1).
    Tanemura K; Chui DH; Fukuda T; Murayama M; Park JM; Akagi T; Tatebayashi Y; Miyasaka T; Kimura T; Hashikawa T; Nakano Y; Kudo T; Takeda M; Takashima A
    J Biol Chem; 2006 Feb; 281(8):5037-41. PubMed ID: 16377636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.
    Eckert A; Schulz KL; Rhein V; Götz J
    Mol Neurobiol; 2010 Jun; 41(2-3):107-14. PubMed ID: 20217279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
    Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination of human tau and islet amyloid polypeptide exacerbates metabolic dysfunction in transgenic mice.
    Wijesekara N; Gonçalves RA; Ahrens R; Ha K; De Felice FG; Fraser PE
    J Pathol; 2021 Jul; 254(3):244-253. PubMed ID: 33797777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
    Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
    Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
    Baker S; Polanco JC; Götz J
    J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
    Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD
    J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.
    Muyllaert D; Terwel D; Borghgraef P; Devijver H; Dewachter I; Van Leuven F
    Rev Neurol (Paris); 2006 Oct; 162(10):903-7. PubMed ID: 17028556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice.
    Oliveira WH; Braga CF; Lós DB; Araújo SMR; França MR; Duarte-Silva E; Rodrigues GB; Rocha SWS; Peixoto CA
    Exp Brain Res; 2021 Sep; 239(9):2821-2839. PubMed ID: 34283253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss.
    Kimura T; Fukuda T; Sahara N; Yamashita S; Murayama M; Mizoroki T; Yoshiike Y; Lee B; Sotiropoulos I; Maeda S; Takashima A
    J Biol Chem; 2010 Dec; 285(49):38692-9. PubMed ID: 20921222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.